文献速递运动医学

脱钙皮质骨基质与骨髓间充质干细胞在慢性肩袖退变模型中的应用

Application of a Demineralized Cortical Bone Matrix and Bone Marrow-Derived Mesenchymal Stem Cells in a Model of Chronic Rotator Cuff Degeneration.
PubMed 文献 · Am J Sports Med · 2017-09-26

研究在大鼠慢性肩袖退变模型中比较脱钙骨基质(DBM)联合间充质干细胞(MSCs)、脱细胞人真皮基质联合MSCs与单纯修复对腱骨愈合的影响。结果显示各组均形成纤维软骨性止点,但仅DBM+MSCs组的骨密度与未手术对照无显著差异,作者认为DBM联合MSCs可促进肩袖愈合。

要点

  • 在大鼠慢性肩袖退变模型中,DBM+MSCs增强修复后6周骨密度与未手术对照无显著差异。
  • 真皮基质+MSCs组止点结构紊乱、胶原排列异常且细胞密度较高。
  • 作者认为DBM联合MSCs可能降低再撕裂发生率,但需进一步研究确定其有效性。

核心结论

  • 脱钙骨基质增强MSCs可在6周时促进肩袖愈合,并使止点骨密度恢复至损伤前水平。

研究设计与样本

  • 对照实验室研究,18只雌性Wistar大鼠行单侧冈上肌腱切断,3周后随机分为3组每组6只进行修复。

主要发现

  • 所有组均实现腱骨间隙闭合并形成纤维软骨性止点。
  • 止点成熟度和改良Movin评分在各组间无显著差异。
  • 真皮基质+MSCs组与其他MSCs组相比,止点结构紊乱、胶原纤维排列异常且细胞密度更高。
  • 仅DBM+MSCs修复组的骨密度与未手术对照相比无显著降低。

关键数值与推荐

  • DBM组接受皮质同种异体脱钙骨基质增强修复(n=6)。
  • 真皮基质组接受非网格化超厚脱细胞人真皮基质增强修复(n=6)。
  • 无支架组仅行腱骨修复(n=6)。
  • 所有动物均在修复部位接受1×10^6个MSCs以纤维蛋白胶递送。

临床怎么用

  • 作者认为,使用DBM和MSCs对肩袖修复进行生物学增强可能减少再撕裂的发生率,但尚需进一步研究确定其有效性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The success of rotator cuff repair is primarily dependent on tendon-bone healing. Failure is common because weak scar tissue replaces the native enthesis, rendering it prone to reruptures. A demineralized bone matrix (DBM) consists of a network of collagen fibers that provide a sustained release of growth factors such as bone morphogenetic proteins. Previous studies have demonstrated that it can regenerate a fibrocartilaginous enthesis. HYPOTHESIS: The use of a DBM and mesenchymal stem cells (MSCs) at the healing enthesis will result in a higher bone mineral density at the tendon insertion and will enhance the regeneration of a morphologically superior enthesis when compared with an acellular human dermal matrix. STUDY DESIGN: Controlled laboratory study. METHODS: Eighteen female Wistar rats underwent unilateral detachment of the supraspinatus tendon. Three weeks later, tendon repair was carried out in animals randomized into 3 groups: group 1 received augmentation of the repair with a cortical allogenic DBM (n = 6); group 2 received augmentation with a nonmeshed, ultrathick, acellular human dermal matrix (n = 6); and group 3 underwent tendon-bone repair without a scaffold (n = 6). All animals received 1 × 106 MSCs delivered in fibrin glue to the repair site. Specimens were retrieved at 6 weeks postoperatively for histological analysis and the evaluation of bone mineral density. RESULTS: All groups demonstrated closure of the tendon-bone gap with a fibrocartilaginous enthesis. Although there were no significant differences in the enthesis maturation and modified Movin scores, repair augmented with a dermal matrix + MSCs exhibited a disorganized enthesis, abnormal collagen fiber arrangement, and greater cellularity compared with other MSC groups. Only repairs augmented with a DBM + MSCs reached a bone mineral density not significantly lower than nonoperated controls. CONCLUSION: A DBM enhanced with MSCs can augment rotator cuff healing at 6 weeks and restore bone mineral density at the enthesis to its preinjury levels. CLINICAL RELEVANCE: Biological augmentation of rotator cuff repair with a DBM and MSCs may reduce the incidence of retears, although further studies are required to determine its effectiveness.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Thangarajah T, Sanghani-Kerai A, Henshaw F, et al. Application of a Demineralized Cortical Bone Matrix and Bone Marrow-Derived Mesenchymal Stem Cells in a Model of Chronic Rotator Cuff Degeneration. Am J Sports Med. 2017. PMID: 28949253. doi:10.1177/0363546517727512

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。